Indeed, to date having molecules able to bias signaling at the FSHR represent important pharmacological tools to understand the specific FSHR signaling pathway contributing to different pathologies both in women and men, such as PCOS and male idiopathic infertility. This evidence concerns the gene FSHR and polycystic ovary syndrome.